Martha Clokie is Professor of Microbiology at the University of Leicester where she leads a group of post-doctoral researchers and PhD students working on different aspects of therapeutic development of phages that target human and animal pathogens. Her work encompasses all aspects of phage therapy development – from unravelling fundamental biology to product development, and commercialisation. She is currently developing phages for major gut pathogens including Clostridial and Salmonella species, for respiratory pathogens and for antibiotic resistant bacteria that cause UTIs. She is also developing a phage based diagnostic test for Borrelia. Three patents have been filed from her work.